CClinicalTrials.gg
RecruitingNCT06472492Updated Mar 27, 2026

Cognitive Enhancement in Unipolar Depression With Yoga

An interventional study of Adjuvant yoga intervention in Unipolar Depression, sponsored by University of Pittsburgh. Recruiting at 1 site in India. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2024; still recruiting 2 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

It is evident from recent studies that cognitive deficits persist even after remission of depressive episode. Hence, in this study, the investigators would like to see whether specific Yoga practice will help in enhancing cognitive abilities in this population.

Read the detailed description

Depression is a common mental health condition affecting many people around the world. It affects the person's mood, thinking (cognition), behavior and also physical health causing difficulty in performing duties in efficient way. Most of these problems can be treated by medicines and/or talk therapies. But the research shows that even after the recovery from most of these problems, most individuals continue to have difficulties in capacity to think properly, they are specifically called as dysfunction in executive functions of our mind. The executive functions are a set of skills which make us possible to play with ideas, taking time to think before acting, meeting novel, unanticipated challenges, resisting temptations, staying focused., etc.

To overcome these problems currently there is no standard solution. However, the previous studies have shown that specific Yoga practices help in overcoming these challenges in general population. Hence it is planned of testing whether regular practice of a specific Yoga along with ongoing treatment for depression would benefit persons in enhancing their thinking capabilities.

Screening procedure:

The screening will be a verbal process where the patient will be verbally asked about the symptoms to check eligibility criteria of this study. If the patient is not eligible after completing this questionnaire, then the participation in this study will end.

(PS: Screening procedures for the study eligibility may involve the review and collection of information from patient's medical record.) This will be followed by obtaining written informed consent from the patient if the person considers participating in the study.

The eligible and consenting participants will be screened for severity of depression using a questionnaire.

After successful entry into the study, the patient will be asked about the demographic details including medical, treatment history.

Later, base line assessments to assess the cognitive functions will be done by the SRF. They are pen and paper tests. Total 3 types of tests will be done which may take around 25 to 30 minutes..

  • Each person will be randomly assigned (like flip of a coin) to either yoga group or treatment as usual group.
  • . If the participant is in the yoga group, he/she will be asked to attend Specific Yoga Practices of duration around 1 Hour every day under a trained therapist for about 6 days in a week for 6 weeks. The cognitive assessments are repeated at the end of 6 weeks and also after a gap of 4 weeks of no yoga practice.
  • The treatment as usual group will undergo regular treatment as usual..
  • The assessments will be repeated after 6 weeks of yoga and after 4 weeks of discontinuation for both participants of yoga group and treatment as usual group.

Total duration - 10 weeks (including 6 weeks of active participation) After the final assessment the TAU participant will be given an option for joining yoga sessions provided in the yoga center at NIMHANS. But this will not be the part of this study Assessment sessions - 3 and Time interval for assessment - Baseline - 6 weeks - 4 weeks

02

Conditions studied

  • Unipolar Depression

Browse trials for

Keywords

  • Unipolar depression
  • Yoga
03

In context

Depressive Disorder

4,845 studies on the registry are indexed under Depressive Disorder; 514 are open to participants now.

This study's planned enrollment of 32 is below the median of 80 across 3,999 interventional studies indexed under Depressive Disorder.

Browse Depressive Disorder studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,385 studies on the registry; 167 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age more than 18years and less than 60 years
  • H/o at least one depressive episode which is under remission and at the time of examination and throughout the study duration,
  • Informed Consent

Exclusion criteria

Exclusion Criteria:

  • Comorbid Psychosis, OCD, Bipolar disorder
  • Comorbid ADHD, IDD
  • Comorbid substance dependence (except tobacco)
  • Comorbid major or minor cognitive impairment,
  • Bi temporal ECT within 6 months
  • Past yoga practice - regularly for 1 month within 3 months Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Adjuvant yoga intervention group

    The yoga group will attend the yoga under the guidance of a therapist for 6 weeks (6 days a week).yoga group, the participant needs to attend Specific Yoga Practices of duration around 1 Hour every day under a trained therapist for about 6 days in a week for 6 weeks, along with your ongoing medications (online/offline).. It includes warme up exercises and asanas.

    Behavioral: Adjuvant yoga intervention

  • No intervention
    Treatment as usual group

    The treatment-as-usual group will continue with usual treatment.the treatment as usual group will continue the ongoing medications for next 6 weeks. But participants will be coming for cognitive assessments at the end of 6 weeks and 4 weeks later. After the final assessment they will be given an option for joining yoga sessions provided in the yoga center at NIMHANS. But this will not be the part of this study.

Interventions

  • BehavioralAdjuvant yoga intervention

    The yoga will include following asanas under the supervision of a yoga therapist. This will include Griva Shithilikarana, Skandha Sanchalana , Kati Sanchalana, Jaanu Sanchalana, Pada Sanchalana, Tadasana, Kati Sakti Vikasaka, Konasana,Marjari Asana, Vakrasana, Pascimottanasana, Matsyasana, Bhujangasana, Ardha Shalabhasana, Viparitakarani, Pavanamuktasana, Setubhandasana, Shavasana, Kapalabhati, Surya-anuloma pranayama, Chandraanuloma pranayama, Bhastrika, Bhramari Pranayama, Nadanusandhana.

06

What researchers measure

Primary outcomes

  1. Working memory (Digit Span)

    To study the change in working memory in intervention group as measured by digit span test in comparison to treatment as usual. The range of the scale is 0 to 28 points and higher is better memory.

    Time frame: Baseline, after six weeks yoga and after four weeks of completion of yoga

  2. Attention and processing speed(Trail A and B)

    To study the change in attention and processing speed in intervention group as measured by Trail A and B test in comparison to treatment as usual. The scoring is based on time taken to complete the test. Less the time taken, better the attention and processing speed.

    Time frame: Baseline, after six weeks yoga and after four weeks of completion of yoga

  3. Cognitive flexibility

    To study the change in cognitive flexibility in intervention group as measured by stroop test test in comparison to treatment as usual. Stroop test also measures time to complete the task and less the time, better the score is.

    Time frame: Baseline,after six weeks yoga and after four weeks of completion of yoga

  4. Cognitive inhibition

    To study the change in cognitive inhibition in intervention group as measured by stroop test test in comparison to treatment as usual.

    Time frame: Baseline,after six weeks yoga and after four weeks of completion of yoga

Secondary outcomes

  1. Sustainability of working memory

    To compare the difference in the working memory 4 weeks post adjuvant yoga intervention, as measured by the scores on Digit span test.test in comparison to treatment as usual.The range of the scale is 0 to 28 points and higher is better memory.

    Time frame: four weeks of completion of yoga

  2. Sustainability of attention and processing speed

    To compare the difference in attention and processing speed 4 weeks post adjuvant yoga intervention, as measured by Trail Making A and B tests. The scoring is based on time taken to complete the task. Less the time taken, more is the attention and processing speed.

    Time frame: four weeks of completion of yoga

  3. Sustainability of cognitive flexibility

    To compare the difference incognitive flexibility 4 weeks post adjuvant yoga intervention, as measured by Stroop test. Stroop test also measures time to complete the task and less the time, better the cognitive flexibility is.

    Time frame: four weeks of completion of yoga

  4. Sustainability of cognitive inhibition

    To compare the difference in cognitive inhibition weeks post adjuvant yoga intervention, as measured by the scores on Stroop test.

    Time frame: four weeks of completion of yoga

07

Study locations

1 of 1 sites recruiting
  • National Institute of Mental Health and Neuroscience (NIMHANS)
    Bengaluru, Karnataka 560029, India
    • Daiveek G Pattanashetty, MD · Contact · daiveek1991@gmail.com · +919482023658
    • Smita N Deshpande, MD · Contact · smitadeshp@gmail.com · +919312654702
    • Daiveek G Pattanashetty, MD · Principal investigator
    • Triptish Bhatia · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in the article, after deidentification (text, tables, figures, and appendices).

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06472492
Lead sponsor
University of Pittsburgh
Collaborators
Fogarty International Center of the National Institute of Health, National Institute of Mental Health and Neuro Sciences, India
Responsible party
Vishwajit Nimgaonkar, MD PhD (Professor, University of Pittsburgh) — Principal investigator
First posted
Jun 25, 2024
Start date
May 17, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Mar 27, 2026

Study contacts

Vishwajit L Nimgaonkar
Contact
vishwajitnl@upmc.edu
4127265164
Triptish Bhatia
Contact
trb16@pitt.edu
+919910107210
Vishwajit L Nimgaonkar, MD, PhD
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion